1-20 of 36
Authors: John Wiencke
Sort by
Journal Article
EPID-22. MUTATIONAL SIGNATURE ASSOCIATED WITH HALOALKANE EXPOSURE ENRICHED IN FIREFIGHTERS IN THE ADULT GLIOMA STUDY
Vincent Cannataro and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii142, https://doi.org/10.1093/neuonc/noae165.0558
Published: 11 November 2024
Journal Article
EPID-32. ELEVATED SERUM IGE IS LINKED TO IMPROVED GLIOBLASTOMA SURVIVAL, PARTICULARLY AMONG FEMALES
Stephen Francis and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii145, https://doi.org/10.1093/neuonc/noae165.0568
Published: 11 November 2024
Journal Article
EPID-19. INTERACTION BETWEEN GERMLINE AND SOMATIC GENETICS TO ELUCIDATE RISK OF ADULT DIFFUSE GLIOMA
Jeanette Eckel-Passow and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii142, https://doi.org/10.1093/neuonc/noae165.0555
Published: 11 November 2024
Journal Article
EPID-02. BLOOD-BASED CLASSIFICATION OF IDH-STATUS OF NON-ENHANCING GLIOMAS: A MACHINE LEARNING APPROACH
Sara Hadad and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii137–viii138, https://doi.org/10.1093/neuonc/noae165.0538
Published: 11 November 2024
Journal Article
EPID-12. SURVIVAL IS ASSOCIATED WITH CIRCULATING B-CELLS AND AGE AMONG OLIGODENDROGLIOMA PATIENTS
Jennie Taylor and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v117–v118, https://doi.org/10.1093/neuonc/noad179.0444
Published: 10 November 2023
Journal Article
EPID-17. ANTIBODY REACTIVITY TO VARICELLA ZOSTER VIRUS IS ASSOCIATED WITH IMPROVED GLIOMA SURVIVAL AND IS MODIFIED BY GERMLINE HLA POLYMORPHISMS
Stephen Francis and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v119, https://doi.org/10.1093/neuonc/noad179.0449
Published: 10 November 2023
Journal Article
BIOM-42. LONGITUDINAL IMMUNE PROFILES OF LOWER GRADE ADULT GLIOMA PATIENTS
Geno Guerra and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v13–v14, https://doi.org/10.1093/neuonc/noad179.0053
Published: 10 November 2023
Journal Article
EPID-02. ANTIBODY REACTIVITY TO VARICELLA-ZOSTER VIRUS AND THREE OTHER HERPESVIRUSES AND SURVIVAL IN ADULTS WITH GLIOMA
Geno Guerra and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii109, https://doi.org/10.1093/neuonc/noac209.412
Published: 14 November 2022
Journal Article
BIOM-43. CROSS-PLATFORM ROBUSTNESS IN THE GLUCOCORTICOID RESPONSE PHARMACODYNAMIC BIOMARKER
Emily Tang and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi20, https://doi.org/10.1093/neuonc/noab196.074
Published: 12 November 2021
Journal Article
EPCO-02. GERMLINE SINGLE NUCLEOTIDE POLYMORPHISM rs55705857 AT 8q24 INTERACTS WITH SOMATIC IDH1 MUTATION TO ENHANCE HUMAN GLIOMA FORMATION
Kristen Drucker and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi1, https://doi.org/10.1093/neuonc/noab196.001
Published: 12 November 2021
Journal Article
SURG-15. A NOVEL RISK MODEL TO DEFINE THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION WITHIN PROGNOSTIC GROUPS IN NEWLY DIAGNOSED DIFFUSE LOW-GRADE GLIOMA
Shawn Hervey-Jumper and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii206, https://doi.org/10.1093/neuonc/noaa215.862
Published: 09 November 2020
Journal Article
SURG-18. THE IMPACT OF NEUROLOGIC IMPAIRMENTS ON THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION IN NEWLY DIAGNOSED IDH-WILD TYPE GLIOBLASTOMA
Shawn Hervey-Jumper and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii207, https://doi.org/10.1093/neuonc/noaa215.865
Published: 09 November 2020
Journal Article
EPID-08. PRE-SURGERY IMMUNE PROFILES OF ADULT GLIOMA PATIENTS
Paige Bracci and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii79–ii80, https://doi.org/10.1093/neuonc/noaa215.326
Published: 09 November 2020
Journal Article
BIOM-13. DNA METHYLATION MARKS GLUCOCORTICOID PATHWAY RESPONSE IN DEXAMETHASONE-TREATED BRAIN TUMOR PATIENTS
John Wiencke and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii4, https://doi.org/10.1093/neuonc/noaa215.013
Published: 09 November 2020
Journal Article
EPCO-25. AN IMMUNOMETHYLOMIC PLATFORM INTEGRATING SYSTEMIC IMMUNE PROFILES AND EPIGENETIC AGE IN NEURO-ONCOLOGY
Annette Molinaro and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii74, https://doi.org/10.1093/neuonc/noaa215.304
Published: 09 November 2020
Journal Article
GENE-25. GWAS BY MOLECULAR SUBTYPE IDENTIFIED NOVEL RISK LOCI FOR ADULT DIFFUSE GLIOMA
Jeanette Eckel-Passow and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi102–vi103, https://doi.org/10.1093/neuonc/noz175.427
Published: 11 November 2019
Journal Article
EPID-12. USING GERMLINE VARIANTS TO PREDICT GLIOMA RISK AND IDENTIFY GLIOMA SUBTYPE PRE-OPERATIVELY
Jeanette Eckel-Passow and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi82, https://doi.org/10.1093/neuonc/noy148.339
Published: 05 November 2018
Journal Article
IMMU-07. IMMUNE PROFILES IN THE SAN FRANCISCO ADULT GLIOMA STUDY (AGS) USING IMMUNOMETHYLOMICS
John Wiencke and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi122, https://doi.org/10.1093/neuonc/noy148.510
Published: 05 November 2018
Journal Article
COMP-05. EVALUATION OF A DEEP LEARNING ARCHITECTURE FOR MRI PREDICTION OF IDH, 1p19q AND TERT IN GLIOMA PATIENTS
Panagiotis Korfiatis and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi64, https://doi.org/10.1093/neuonc/noy148.260
Published: 05 November 2018
Journal Article
SURG-02. A NOVEL RISK MODEL TO DEFINE THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION WITHIN PROGNOSTIC GROUPS IN NEWLY DIAGNOSED GLIOBLASTOMA
Annette Molinaro and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi250, https://doi.org/10.1093/neuonc/noy148.1038
Published: 05 November 2018
Advertisement
Advertisement